The global biobanks market is expected to reach USD 83.82 billion by 2028, according to a new report by Reports and Data. Rising demand for stem cell preservation of newborns is instrumental in fuelling the growth of the market. Stem cells have the capability of discerning and regenerating various kinds of cells in the human body. These cells possess the potential to cure life-threatening diseases such as oncological and blood-related disorders. Cord blood stem cells find application in the treatment of more than 80 blood-related ailments, such as Sickle Cell Disease. It is projected that over 27 million babies across the globe are born with some kind of blood disorder. As per the World Health Organization, in 2008, 100,000 children were found to e suffering from thalassemia in India. Constant researches are being carried out all over the world to study the usage of umbilical cord blood and tissue stem cell for the treatment of fatal diseases.
To get a sample copy of the report, click on https://www.reportsanddata.com/sample-enquiry-form/3083
In-depth Study of the Competitive Landscape:
The global Biobanks Market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence.
Top companies profiled in the report include:
Becton, Dickinson, and Company, Merck KGaA, Thermo Fisher Scientific Inc., Tecan Trading AG, Panasonic Healthcare Holdings Co. Ltd., Hamilton Company, VWR Corporation, Brooks Automation Inc., Promega Corporation, and Chart Industries Inc., among others.
Key Market Regions Covered in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
For More Information Click Here: https://www.reportsanddata.com/press-release/global-biobanks-market
Type Outlook (Revenue, USD Million; 2018-2028)
- Disease-Oriented Biobanks
- Population-Based Biobanks
Storage Type Outlook (Revenue, USD Million; 2018-2028)
- Manual Storage
- Automated Storage
Product Outlook (Revenue, USD Million; 2018-2028)
- Equipment
- Consumables
- Software
- Services
Specimen Type Outlook (Revenue, USD Million; 2018-2028)
- Human Organs
- Human Tissues
- Stem Cells
- Others
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Biobanks Market over the forecast period?
- What are the major factors driving the growth of the Global Biobanks Market?
- What are the key challenges impacting the global Biobanks Market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3083
Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.
